Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of B-Myb activity by cyclin D1

Oncogene volume 19, pages 298–306 (2000)Cite this article

Abstract

Evidence obtained during recent years suggests that B-Myb, a highly conserved member of the Myb transcription factor family, plays a key role in cell proliferation. We have shown previously that the activity of B-Myb is stimulated by cyclin A/Cdk2-dependent phosphorylation of the carboxyl-terminus of B-Myb. We have now investigated in more detail the effect of other cyclins on B-Myb. Here, we show that cyclin D1, in contrast to cyclin A, strongly inhibits the activity of B-Myb. This inhibitory effect does not involve increased phosphorylation of B-Myb but seems to rely on the formation of a specific complex of B-Myb and cyclin D1. Our work identifies B-Myb as an interacting partner for cyclin D1 and suggest that the activity of B-Myb during the cell cycle is controlled by the antagonistic effects of cyclin D1 and A. The results presented here suggest a more general role of cyclin D1 as regulator of transcription in addition to the known effect on RB phosphorylation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Arsura M, Introna M, Passerini F, Mantovani A and Golay J . 1992 Blood 79: 2708–2716.

  • Bartsch O, Horstmann S, Toprak K, Klempnauer K-H and Ferrari S . 1999 Eur J Biochem 260: 384–391.

  • Beijersbergen RL, Carlee L, Kerkhoven RM and Bernards R . 1995 Genes Dev 9: 1340–1353.

  • Bouwmeester T, Guehmann S, El-Baradi T, Kalkbrenner F, van Wijk I, Moelling K and Pieler T . 1992 Mech Dev 37: 57–68.

  • Carr MD, Wollborn U, McIntosh PB, Frenkiel TA, McCormick JE, Bauer CJ, Klempnauer K-H and Feeney J . 1996 Eur J Biochem 235: 721–735.

  • Diehl JA, Cheng M, Roussel MF and Sherr CJ . 1998 Genes Dev 12: 3499–3511.

  • Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA . 1993 Cell 73: 499–511.

  • Draetta GF . 1994 Curr Opin Cell Biol 6: 842–846.

  • Ferrari S, Bannwarth W, Morley SJ, Totty NF and Thomas G . 1992 Proc Natl Acad Sci USA 89: 7282–7286.

  • Foos G, Grimm S and Klempnauer K-H . 1992 EMBO J 11: 4619–4629.

  • Ganter B, Fu S-L and Lipsick JS . 1998 EMBO J 17: 225–268.

  • Graf T . 1992 Curr Opin Genet Dev 2: 249–255.

  • Hinds PW, Dowdy SF, Eaton EN, Arnold A and Weinberg RA . 1994 Proc Natl Acad Sci USA 91: 709–713.

  • Hirai H and Sherr CJ . 1996 Mol Cell Biol 16: 6457–6467.

  • Inoue K and Sherr CJ . 1998 Mol Cell Biol 18: 1590–1600.

  • Kamano H, Burk B, Noben-Trauth K and Klempnauer K-H . 1995 Oncogene 11: 2575–2582.

  • Kamano H and Klempnauer K-H . 1997 Oncogene 14: 1223–1229.

  • Lam EW-F and Watson RJ . 1993 EMBO J 12: 2705–2713.

  • Lam EW-F, Robinson C and Watson RJ . 1992 Oncogene 7: 1885–1890.

  • Lane S, Farlie P and Watson R . 1997 Oncogene 14: 2445–2453.

  • Lin D, Fiscella M, O'Connor PM, Kackman J, Chen M, Luo LL, Sala A, Travali S, Apella E and Mercer EW . 1994 Proc Natl Acad Sci USA 91: 10079–10083.

  • Massagué J and Roberts JM . 1995 Curr Opin Cell Biol 7: 769–772.

  • Matsushime H, Roussel MF, Ashumun RA and Sherr CJ . 1991 Cell 65: 701–713.

  • Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JY . 1994 Mol Cell Biol 14: 2066–2076.

  • Mink S, Mutschler B, Weiskirchen R, Bister K and Klempnauer K-H . 1996 Proc Natl Acad Sci USA 93: 6635–6640.

  • Mizuguchi G, Nakagoshi H, Nagase T, Nomura N, Date T, Ueno Y and Ishii S . 1990 J Biol Chem 265: 9280–9284.

  • Morgan DO . 1995 Nature 374: 131–134.

  • Morgan DO . 1997 Ann Rev Cell Dev Biol 13: 261–291.

  • Ness SA, Marknell A and Graf T . 1989 Cell 59: 1115–1125.

  • Neuman E, Ladha MH, Liu N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M and Ewen ME . 1997 Mol Cell Biol 17: 5338–5347.

  • Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S and Ishizaki R . 1988 Nucleic Acids Res 16: 11075–11089.

  • Robinson C, Light Y, Groves R, Mann D, Marais R and Watson R . 1996 Oncogene 12: 1855–1864.

  • Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K and Peschle C . 1997 Proc Natl Acad Sci USA 94: 532–536.

  • Saville MK and Watson RJ . 1998 Oncogene 17: 2679–2689.

  • Sherr CJ . 1993 Cell 73: 1059–1065.

  • Sherr CJ . 1995 Trends in Biol Sci 20: 187–190.

  • Sherr CJ and Roberts JM . 1995 Genes Dev 9: 1149–1163.

  • Sitzmann J, Noben-Trauth K and Klempnauer K-H . 1996 Oncogene 12: 1889–1894.

  • Skapek SX, Rhee J, Spicer DB and Lassar AB . 1995 Science 267: 1022–1024.

  • Skapek SX, Rhee J, Kim PS, Novitch BG and Lassar AB . 1996 Mol Cell Biol 16: 7043–7053.

  • Toscani A, Mettus RV, Coupland R, Simpkins H, Litvin J, Orth J, Hetton KS and Reddy EP . 1997 Nature 386: 713–717.

  • Trauth K, Mutschler B, Jenkins NA, Gilbert DJ, Copeland NG and Klempnauer K-H . 1994 EMBO J 13: 5994–6005.

  • Watson RJ, Robinson C and Lam EW-F . 1993 Nucleic Acids Res 21: 267–272.

  • Weinberg RA . 1995 Cell 81: 323–330.

  • Won K-A, Xiong Y, Beach D and Gilman MZ . 1992 Proc Natl Acad Sci USA 89: 9910–9914.

  • Ziebold U, Bartsch O, Marais R, Ferrari S and Klempnauer K-H . 1997 Curr Biol 7: 253–260.

  • Ziebold U and Klempnauer K-H . 1997 Oncogene 15: 1011–1019.

  • Zwicker J, Liu N, Engeland K, Lucibello FC and Müller R . 1996 Science 271: 1595–1597.

  • Zwijsen RML, Wientjens E, Klompmaker R, van der Sman J, Bernards R and Michalides RJAM . 1997 Cell 88: 405–415.

Download references

Acknowledgements

We thank A Brehmer-Fastnacht, B Mutschler and D Wenning for excellent technical assistance, U Ziebold for discussions and R Weinberg for providing plasmids. This study was supported by grants from the DFG to K-H Klempnauer (K1 461/5-3 and K1 461/9-1) and to S Ferrari (Fe 387/1-1).

Author information

Author notes

  1. Stefano Ferrari

    Present address: Department of Oncology, Novartis Pharma AG, K-125.4.01, Basel, CH-4002, Switzerland

Authors and Affiliations

  1. Institute of Biochemistry, University of Münster, Wilhelm-Klemm-Str. 2, D-48149 Münster, Germany

    Sebastian Horstmann & Karl-Heinz Klempnauer

  2. Institute for Experimental Cancer Research, Tumor Biology Center, PO Box 1120, Freiburg, D-79011, Germany

    Stefano Ferrari

Authors
  1. Sebastian Horstmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl-Heinz Klempnauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horstmann, S., Ferrari, S. & Klempnauer, KH. Regulation of B-Myb activity by cyclin D1. Oncogene 19, 298–306 (2000). https://doi.org/10.1038/sj.onc.1203302

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203302

Keywords

This article is cited by

Search

Advanced search

Quick links